LifeMD, Inc.LFMD
Price (close)
$2.91
Market cap
$139.2M
P/E
692.3x
Revenue (TTM)
$164.7M
Net income
$201,011
Dividend yield
—
1-year total return
-53.2%
Net margin
0.1%
Revenue growth
3.8%
Debt / equity
2.00x
What LifeMD, Inc. does.
is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients
to access virtual medical care and pharmacy services. We believe the traditional healthcare model requiring patients to visit a physician’s
office, travel to a retail pharmacy, and return for follow-up appointments or prescription refills is complex, inefficient, and costly
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $37.3M | $92.9M | $119.0M | $152.5M | $154.8M | $194.1M |
| Net income | -$58.6M | -$60.9M | -$45.5M | -$20.6M | -$21.4M | $14.4M |
| Free cash flow | — | -$33.3M | -$23.3M | $8.6M | $16.0M | $6.4M |
More on LFMD.
- LifeMD, Inc. summary
- LifeMD, Inc. financial statements
- LifeMD, Inc. key metrics
- LifeMD, Inc. health scores and style box
- LifeMD, Inc. earnings
- LifeMD, Inc. dividends
- LifeMD, Inc. valuation
- LifeMD, Inc. ownership and insiders
- LifeMD, Inc. peers
Figures from LifeMD, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.